Monopar Therapeutics Inc. (MNPR) Financial Statements (2024 and earlier)

Company Profile

Business Address 1000 SKOKIE BLVD SUITE 350
WILMETTE, IL 60091
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:12,18220,30416,73713,2146,8938,982
Cash and cash equivalents8,18620,30416,73713,2146,8938,982
Other undisclosed cash, cash equivalents, and short-term investments 3,996     
Deferred costs    10  
Other current assets4621863   
Other undisclosed current assets937  5425149
Total current assets:13,16620,52216,80013,2307,3189,131
Noncurrent Assets
Operating lease, right-of-use asset61   
Other noncurrent assets   69122  
Other undisclosed noncurrent assets      800
Total noncurrent assets:61 69122 800
TOTAL ASSETS:13,22720,52216,86913,3527,3189,931
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3,1291,5811,177724400312
Other undisclosed accounts payable and accrued liabilities3,1291,5811,177724400312
Total current liabilities:3,1291,5811,177724400312
Noncurrent Liabilities
Liabilities, other than long-term debt 8     
Operating lease, liability 8   
Total noncurrent liabilities: 8     
Total liabilities:3,1371,5811,177724400312
Equity
Equity, attributable to parent10,09018,94115,69212,6286,9189,619
Common stock1313111199
Additional paid in capital61,87260,22047,87438,50928,56728,038
Accumulated other comprehensive income (loss)9(3)(8)(11)(2) 
Accumulated deficit(51,804)(41,288)(32,185)(25,881)(21,656)(18,428)
Total equity:10,09018,94115,69212,6286,9189,619
TOTAL LIABILITIES AND EQUITY:13,22720,52216,86913,3527,3189,931

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues
(Other Income)
   122   
Cost of revenue
(Cost of Goods and Services Sold)
 (83)     
Gross profit: (83) 122   
Operating expenses(10,537)(9,127)(6,509)(4,324)(3,403)(16,603)
Other undisclosed operating income (loss) 83 (122)   
Operating loss:(10,537)(9,127)(6,509)(4,324)(3,403)(16,603)
Loss from continuing operations before equity method investments, income taxes:(10,537)(9,127)(6,509)(4,324)(3,403)(16,603)
Other undisclosed income from continuing operations before income taxes     103 
Loss from continuing operations:(10,537)(9,127)(6,509)(4,324)(3,300)(16,603)
Loss before gain (loss) on sale of properties:(9,127)(6,509)(4,324)(3,300)(16,603)
Other undisclosed net income21     
Net loss:(10,516)(9,127)(6,509)(4,324)(3,300)(16,603)
Other undisclosed net income attributable to parent 24204997248
Net loss available to common stockholders, diluted:(10,516)(9,103)(6,305)(4,225)(3,228)(16,555)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(10,516)(9,127)(6,509)(4,324)(3,300)(16,603)
Other comprehensive income (loss) 1253(9)(2) 
Other undisclosed comprehensive income      
Comprehensive loss:(10,504)(9,123)(6,506)(4,332)(3,302)(16,603)
Other undisclosed comprehensive income, net of tax, attributable to parent 242049972 
Comprehensive loss, net of tax, attributable to parent:(10,504)(9,099)(6,301)(4,233)(3,230)(16,603)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: